American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4003)
  2. Hematologic Malignancies, Division of (3806)
  3. Center for Hematologic Malignancies (3683)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1345)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (989)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1261)
  3. Research Letter (46)
  4. Review (43)
  5. Editorial (35)
  6. Guidelines (14)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4003)
  2. Hematologic Malignancies, Division of (3806)
  3. Center for Hematologic Malignancies (3683)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1345)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (349)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (68)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5175)
  2. Blood Advances (334)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5559)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An analysis of the transcriptional response of myelodysplastic syndrome stem cells to therapy at single cell resolution
    Meeting Abstract

    Chung, S. S.; Vijay, P.; Stern, D. L.; Klimek, V. M.; Mason, C. E.; Park, C. Y.
    Blood (2016)

    Fulltext@MSK | Save
  • Safety and efficacy of carfilzomib (CFZ) in previously-treated systemic light-chain (AL) amyloidosis
    Meeting Abstract

    Cohen, A. D.; Landau, H.; Scott, E. C.; Liedtke, M.; Kaufman, J. L.; Rosenzweig, M.; Gasparetto, C.; Vesole, D. H.; Sanchorawala, V.; Lentzsch, S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Despite increasing size of unrelated donor (URD) registries and the global cord blood (CB) inventory racial disparities in access to URD and CB grafts persist: A prospective 10 year analysis of 1,112 patients
    Meeting Abstract

    Boughan, K.; Dahi, P. B.; Devlin, S.; Byam, C.; Yoo, Y.; Mazis, C.; Davis, E.; Nhaissi, M.; Paulson, J.; Wells, D.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Aberrant phosphorylation of MEF2C is dispensable for hematopoiesis, and induces chemotherapy resistance and susceptibility to MARK kinase inhibition therapy in acute myeloid leukemia
    Meeting Abstract

    Brown, F. C.; Still, E.; Cifani, P.; Reed, C.; Ficarro, S.; He, J.; Koche, R.; Bhola, P.; Romanienko, P.; Mark, W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The preclinical efficacy of a novel telomerase inhibitor, imetelstat, in AML - A randomized trial in patient-derived xenografts
    Meeting Abstract

    Bruedigam, C.; Wackrow, B.; Song, A.; Porter, A. H.; Lee, S. C. W.; Moore, A. S.; Abdel-Wahab, O.; Lane, S. W.
    Blood (2016)

    Fulltext@MSK | Save
  • H3B-8800, an orally bioavailable modulator of the SF3b complex, shows efficacy in spliceosome-mutant myeloid malignancies
    Meeting Abstract

    Buonamici, S.; Yoshimi, A.; Thomas, M.; Seiler, M.; Chan, B.; Caleb, B.; Darman, R.; Fekkes, P.; Karr, C.; Keaney, G. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • IL-18 secreting CAR T cells enhance cell persistence, induce prolonged B cell aplasia and eradicate CD19+ tumor cells without need for prior conditioning
    Meeting Abstract

    Avanzi, M. P.; van Leeuwen, D. G.; Li, X.; Cheung, K.; Park, H.; Purdon, T. J.; Brentjens, R. J.
    Blood (2016)

    Fulltext@MSK | Save
  • Pembrolizumab in combination with pomalidomide and dexamethasone for relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Badros, A. Z.; Hyjek, E.; Ma, N.; Lesokhin, A. M.; Rapoport, A. P.; Kocoglu, M. H.; Lederer, E.; Philip, S.; Lesho, P.; Johnson, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Comparison of peripheral blood stem cells (PBSC) to bone marrow (BM) for T-replete HLA-haploidentical donor transplantation using post-transplant cyclophosphamide
    Meeting Abstract

    Bashey, A.; Zhang, M.; McCurdy, S. R.; Ciurea, S. O.; St Martin, A.; Anasetti, C.; Argall, T.; Fasan, O. O.; Gaballa, S.; Hamadani, M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The outcome of patients with primary refractory or relapsed peripheral T-cell lymphoma: Analysis of 1020 cases registered in the prospective T-cell project
    Meeting Abstract

    Bellei, M.; Foss, F. M.; Horwitz, S. M.; Marcheselli, L.; Kim, W. S.; Cabrera, M. E.; Dlouhy, I.; Nagler, A.; Advani, R. H.; Pesce, E.; more...
    Blood (2016)

    Fulltext@MSK | Save